SCHEMBL44573

SCHEMBL44573

C=CCC(C(OC)OC)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.36
TSHR P16473 4/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
ADRA2B P18089 2/20 0.35
ADRA2C P18825 2/20 0.35
SLC6A2 P23975 2/20 0.35
HTR2A P28223 2/20 0.35
ADRA1A P35348 2/20 0.35
SLC6A3 Q01959 2/20 0.35
KCNH2 Q12809 2/20 0.35
SLC22A2 O15244 1/20 0.35
SLC22A1 O15245 1/20 0.35
SLC22A3 O75751 1/20 0.35
ESR1 P03372 1/20 0.35
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADORA3 P0DMS8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15070154 0.86 SIGMAR1 (0.37) SMN1; SMN2TSHRALDH1A1GAASIGMAR1
SCHEMBL40135 0.82 TSHR (0.34) SMN1; SMN2TSHRALDH1A1GAASIGMAR1
SCHEMBL44789 0.82 TSHR (0.34) SMN1; SMN2TSHRALDH1A1GAASIGMAR1
SCHEMBL38834 0.82 BCHE (0.34) SMN1; SMN2TSHRALDH1A1GAASIGMAR1
SCHEMBL45416 0.82 SIGMAR1 (0.46) SMN1; SMN2TSHRALDH1A1SIGMAR1ADRA2B
SCHEMBL44025 0.80 TSHR (0.41) SMN1; SMN2TSHRALDH1A1GAASIGMAR1
SCHEMBL44989 0.73 SIGMAR1 (0.41) SMN1; SMN2TSHRALDH1A1GAASIGMAR1
SCHEMBL3331448 0.73 SIGMAR1 (0.44) SMN1; SMN2TSHRALDH1A1GAASIGMAR1
SCHEMBL44484 0.73 CSNK1E (0.41) SIGMAR1KCNH2CNR2
SCHEMBL29158569 0.71 MEN1 (0.40) SMN1; SMN2TSHRALDH1A1ADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9079824-B2 Method for the synthesis of an amino acetal NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2015-07-14 US disclosed
US-20130165682-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-06-27 US disclosed
WO-2012005693-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-01-12 WO disclosed
WO-2012005693-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165682-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL AOX1, DAO, ALDH7A1 SMN1; SMN2 2065/4885TSHR 3830/4885ALDH1A1 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.